Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 25 February, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 526169 | NSE: MULTIBASE

Multibase India Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: February 24, 2025, 9:17 pm

Market Cap 356 Cr.
Current Price 282
High / Low 622/226
Stock P/E24.4
Book Value 110
Dividend Yield18.8 %
ROCE11.6 %
ROE8.58 %
Face Value 10.0
PEG Ratio1.46

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Multibase India Ltd

Competitors of Multibase India Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Multibase India Ltd 356 Cr. 282 622/22624.4 11018.8 %11.6 %8.58 % 10.0
Harshdeep Hortico Ltd 100 Cr. 62.2 86.0/39.012.1 26.10.00 %50.1 %35.2 % 10.0
TPL Plastech Ltd 674 Cr. 86.5 136/51.429.5 17.20.93 %19.0 %15.8 % 2.00
Sintex Plastics Technology Ltd 67.4 Cr. 1.06 1.35/0.75 0.310.00 %%% 1.00
Plastiblends India Ltd 533 Cr. 205 399/19515.4 1622.07 %11.1 %8.26 % 5.00
Industry Average417.20 Cr149.2288.4855.003.11%16.94%12.31%6.86

All Competitor Stocks of Multibase India Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 13.8118.8118.2018.9816.9918.0418.0816.2615.7414.6519.2318.4217.15
Expenses 12.8115.9516.9717.7215.0812.8116.1615.1713.6011.4815.6314.4114.78
Operating Profit 1.002.861.231.261.915.231.921.092.143.173.604.012.37
OPM % 7.24%15.20%6.76%6.64%11.24%28.99%10.62%6.70%13.60%21.64%18.72%21.77%13.82%
Other Income 0.760.840.881.180.881.651.671.781.882.451.932.021.13
Interest 0.000.060.000.000.000.050.020.000.000.080.000.000.00
Depreciation 0.240.230.280.270.290.160.310.200.250.260.270.280.29
Profit before tax 1.523.411.832.172.506.673.262.673.775.285.265.753.21
Tax % 27.63%27.27%25.14%26.73%25.20%25.64%25.46%24.72%27.06%25.38%25.48%25.39%25.86%
Net Profit 1.102.471.371.581.874.962.442.012.763.953.924.292.38
EPS in Rs 0.871.961.091.251.483.931.931.592.193.133.113.401.89

Last Updated: February 22, 2025, 12:18 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 20, 2025, 2:19 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 4555627086109110605362726569
Expenses 39475156688090534756635656
Operating Profit 67101419292077710813
OPM % 14%13%17%20%22%26%18%11%13%11%13%13%19%
Other Income 1112223443588
Interest 0000000000000
Depreciation 0011111111111
Profit before tax 78111520302210109131520
Tax % 31%33%34%35%35%35%30%24%32%27%26%26%
Net Profit 45710132015876101115
EPS in Rs 3.564.035.727.8310.5215.4912.175.975.325.027.768.8411.53
Dividend Payout % 0%0%0%0%0%0%0%0%38%20%26%34%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)25.00%40.00%42.86%30.00%53.85%-25.00%-46.67%-12.50%-14.29%66.67%10.00%
Change in YoY Net Profit Growth (%)0.00%15.00%2.86%-12.86%23.85%-78.85%-21.67%34.17%-1.79%80.95%-56.67%

Multibase India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:2%
5 Years:-10%
3 Years:7%
TTM:2%
Compounded Profit Growth
10 Years:8%
5 Years:-6%
3 Years:18%
TTM:19%
Stock Price CAGR
10 Years:0%
5 Years:18%
3 Years:11%
1 Year:0%
Return on Equity
10 Years:12%
5 Years:7%
3 Years:7%
Last Year:9%

Last Updated: Unknown

Balance Sheet

Last Updated: Unknown

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 13131313131313131313131313
Reserves 1621293852718794101105113122126
Borrowings 0000000000000
Other Liabilities 7768123212101212111014
Total Liabilities 3641475977116111117126130137144153
Fixed Assets 555891010111011111212
CWIP 0000000000000
Investments 0000000000000
Other Assets 3236425168106101106115119126133141
Total Assets 3641475977116111117126130137144153

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +-037752552010595
Cash from Investing Activity +-21-974-3032-02134
Cash from Financing Activity +-0-00000-10100-2-1-3
Net Cash Flow-33-1148-52631123106

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow6.007.0010.0014.0019.0029.0020.007.007.007.0010.008.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days767160678180617177645851
Inventory Days12610584106128132831061231036195
Days Payable77523652661574372101795554
Cash Conversion Cycle1251241081201445610110698886491
Working Capital Days134120105103121721319890786277
ROCE %25%24%29%33%35%40%24%10%9%8%11%12%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%
FIIs1.03%1.03%1.03%0.33%0.33%0.33%0.33%0.33%0.33%0.17%0.17%0.17%
Public23.97%23.97%23.98%24.67%24.68%24.68%24.67%24.68%24.66%24.82%24.83%24.82%
No. of Shareholders8,4588,4008,4318,3918,2378,1388,5788,6558,6379,1379,24217,557

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 8.847.765.025.325.97
Diluted EPS (Rs.) 8.847.765.025.325.97
Cash EPS (Rs.) 9.648.555.776.116.73
Book Value[Excl.RevalReserv]/Share (Rs.) 106.6399.8093.0690.0584.71
Book Value[Incl.RevalReserv]/Share (Rs.) 106.6399.8093.0690.0584.71
Dividend / Share (Rs.) 3.002.001.002.000.00
Revenue From Operations / Share (Rs.) 51.3057.2249.5142.3547.37
PBDIT / Share (Rs.) 12.7611.267.638.588.65
PBIT / Share (Rs.) 11.9610.476.887.797.89
PBT / Share (Rs.) 11.8810.436.847.797.89
Net Profit / Share (Rs.) 8.847.765.025.325.97
PBDIT Margin (%) 24.8719.6815.4120.2518.26
PBIT Margin (%) 23.3118.2913.8918.3916.66
PBT Margin (%) 23.1618.2313.8018.3916.66
Net Profit Margin (%) 17.2213.5510.1412.5612.61
Return on Networth / Equity (%) 8.287.775.395.907.05
Return on Capital Employeed (%) 11.0310.327.298.549.19
Return On Assets (%) 7.727.134.885.336.46
Asset Turnover Ratio (%) 0.450.540.480.440.52
Current Ratio (X) 17.2413.7511.0910.8112.61
Quick Ratio (X) 15.7112.829.919.6811.21
Inventory Turnover Ratio (X) 2.802.512.161.751.79
Dividend Payout Ratio (NP) (%) 22.6312.8939.810.000.00
Dividend Payout Ratio (CP) (%) 20.7511.6934.640.000.00
Earning Retention Ratio (%) 77.3787.1160.190.000.00
Cash Earning Retention Ratio (%) 79.2588.3165.360.000.00
Interest Coverage Ratio (X) 160.74307.62172.580.000.00
Interest Coverage Ratio (Post Tax) (X) 112.30212.87114.610.000.00
Enterprise Value (Cr.) 186.74114.54148.81150.1825.91
EV / Net Operating Revenue (X) 2.881.592.382.810.43
EV / EBITDA (X) 11.598.0615.4513.872.37
MarketCap / Net Operating Revenue (X) 4.593.033.894.511.76
Retention Ratios (%) 77.3687.1060.180.000.00
Price / BV (X) 2.211.742.072.120.98
Price / Net Operating Revenue (X) 4.593.033.894.511.76
EarningsYield 0.030.040.020.020.07

After reviewing the key financial ratios for Multibase India Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 8.84. This value is within the healthy range. It has increased from 7.76 (Mar 23) to 8.84, marking an increase of 1.08.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 8.84. This value is within the healthy range. It has increased from 7.76 (Mar 23) to 8.84, marking an increase of 1.08.
  • For Cash EPS (Rs.), as of Mar 24, the value is 9.64. This value is within the healthy range. It has increased from 8.55 (Mar 23) to 9.64, marking an increase of 1.09.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 106.63. It has increased from 99.80 (Mar 23) to 106.63, marking an increase of 6.83.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 106.63. It has increased from 99.80 (Mar 23) to 106.63, marking an increase of 6.83.
  • For Dividend / Share (Rs.), as of Mar 24, the value is 3.00. This value is within the healthy range. It has increased from 2.00 (Mar 23) to 3.00, marking an increase of 1.00.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 51.30. It has decreased from 57.22 (Mar 23) to 51.30, marking a decrease of 5.92.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 12.76. This value is within the healthy range. It has increased from 11.26 (Mar 23) to 12.76, marking an increase of 1.50.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 11.96. This value is within the healthy range. It has increased from 10.47 (Mar 23) to 11.96, marking an increase of 1.49.
  • For PBT / Share (Rs.), as of Mar 24, the value is 11.88. This value is within the healthy range. It has increased from 10.43 (Mar 23) to 11.88, marking an increase of 1.45.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 8.84. This value is within the healthy range. It has increased from 7.76 (Mar 23) to 8.84, marking an increase of 1.08.
  • For PBDIT Margin (%), as of Mar 24, the value is 24.87. This value is within the healthy range. It has increased from 19.68 (Mar 23) to 24.87, marking an increase of 5.19.
  • For PBIT Margin (%), as of Mar 24, the value is 23.31. This value exceeds the healthy maximum of 20. It has increased from 18.29 (Mar 23) to 23.31, marking an increase of 5.02.
  • For PBT Margin (%), as of Mar 24, the value is 23.16. This value is within the healthy range. It has increased from 18.23 (Mar 23) to 23.16, marking an increase of 4.93.
  • For Net Profit Margin (%), as of Mar 24, the value is 17.22. This value exceeds the healthy maximum of 10. It has increased from 13.55 (Mar 23) to 17.22, marking an increase of 3.67.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 8.28. This value is below the healthy minimum of 15. It has increased from 7.77 (Mar 23) to 8.28, marking an increase of 0.51.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 11.03. This value is within the healthy range. It has increased from 10.32 (Mar 23) to 11.03, marking an increase of 0.71.
  • For Return On Assets (%), as of Mar 24, the value is 7.72. This value is within the healthy range. It has increased from 7.13 (Mar 23) to 7.72, marking an increase of 0.59.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.45. It has decreased from 0.54 (Mar 23) to 0.45, marking a decrease of 0.09.
  • For Current Ratio (X), as of Mar 24, the value is 17.24. This value exceeds the healthy maximum of 3. It has increased from 13.75 (Mar 23) to 17.24, marking an increase of 3.49.
  • For Quick Ratio (X), as of Mar 24, the value is 15.71. This value exceeds the healthy maximum of 2. It has increased from 12.82 (Mar 23) to 15.71, marking an increase of 2.89.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.80. This value is below the healthy minimum of 4. It has increased from 2.51 (Mar 23) to 2.80, marking an increase of 0.29.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 22.63. This value is within the healthy range. It has increased from 12.89 (Mar 23) to 22.63, marking an increase of 9.74.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 20.75. This value is within the healthy range. It has increased from 11.69 (Mar 23) to 20.75, marking an increase of 9.06.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 77.37. This value exceeds the healthy maximum of 70. It has decreased from 87.11 (Mar 23) to 77.37, marking a decrease of 9.74.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 79.25. This value exceeds the healthy maximum of 70. It has decreased from 88.31 (Mar 23) to 79.25, marking a decrease of 9.06.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 160.74. This value is within the healthy range. It has decreased from 307.62 (Mar 23) to 160.74, marking a decrease of 146.88.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 112.30. This value is within the healthy range. It has decreased from 212.87 (Mar 23) to 112.30, marking a decrease of 100.57.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 186.74. It has increased from 114.54 (Mar 23) to 186.74, marking an increase of 72.20.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.88. This value is within the healthy range. It has increased from 1.59 (Mar 23) to 2.88, marking an increase of 1.29.
  • For EV / EBITDA (X), as of Mar 24, the value is 11.59. This value is within the healthy range. It has increased from 8.06 (Mar 23) to 11.59, marking an increase of 3.53.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.59. This value exceeds the healthy maximum of 3. It has increased from 3.03 (Mar 23) to 4.59, marking an increase of 1.56.
  • For Retention Ratios (%), as of Mar 24, the value is 77.36. This value exceeds the healthy maximum of 70. It has decreased from 87.10 (Mar 23) to 77.36, marking a decrease of 9.74.
  • For Price / BV (X), as of Mar 24, the value is 2.21. This value is within the healthy range. It has increased from 1.74 (Mar 23) to 2.21, marking an increase of 0.47.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.59. This value exceeds the healthy maximum of 3. It has increased from 3.03 (Mar 23) to 4.59, marking an increase of 1.56.
  • For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Multibase India Ltd as of February 25, 2025 is: ₹218.86

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 25, 2025, Multibase India Ltd is Overvalued by 22.39% compared to the current share price ₹282.00

Intrinsic Value of Multibase India Ltd as of February 25, 2025 is: 255.48

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 25, 2025, Multibase India Ltd is Overvalued by 9.40% compared to the current share price ₹282.00

Last 5 Year EPS CAGR: 16.73%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 21.67%, which is a positive sign.
  2. The company has higher reserves (75.00 cr) compared to borrowings (0.00 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (70.62 cr) and profit (14.62 cr) over the years.
  1. The stock has a high average Working Capital Days of 99.25, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 102.08, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Multibase India Ltd:
    1. Net Profit Margin: 17.22%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 11.03% (Industry Average ROCE: 16.94%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 8.28% (Industry Average ROE: 12.31%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 112.3
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 15.71
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 24.4 (Industry average Stock P/E: 88.48)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Multibase India Ltd. is a Public Limited Listed company incorporated on 17/12/1991 and has its registered office in the State of Daman & Diu, India. Company's Corporate Identification Number(CIN) is L01122DD1991PLC002959 and registration number is 002959. Currently Company is involved in the business activities of Manufacture of mixture of synthetic and natural or rubber like gums. Company's Total Operating Revenue is Rs. 64.74 Cr. and Equity Capital is Rs. 12.62 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Plastics - Plastic & Plastic Products74/5-6, Daman Industrial Estate, Kadaiya Village, Nani-Daman Daman & Diu 396210compliance.officer@multibaseindia.com
http://www.multibaseindia.com
Management
NamePosition Held
Mr. Deepak DhanakManaging Director
Mr. Krishan Kumar PhophaliaNon Executive Director
Mr. Mark Stephen MetaxasNon Executive Director
Ms. Bharti DharInd. Non-Executive Director
Mr. Piyush ChhajedInd. Non-Executive Director
Mr. B RenganathanInd. Non-Executive Director

FAQ

What is the latest intrinsic value of Multibase India Ltd?

Let's break down Multibase India Ltd's intrinsic value simply:

We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.

As of 24 February 2025:

  • Calculated Fair Value: ₹218.86
  • Current Market Price: ₹282.00
  • Variance: 22.39% lower

This suggests Multibase India Ltd is currently overvalued by 22.39%. For context:

  • Market Cap: 356 Cr.
  • 52-Week Range: 622/226
  • Reserves (Sep 2024): ₹126 Cr
  • Liabilities: 153 Cr

Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.

What is the Market Cap of Multibase India Ltd?

The Market Cap of Multibase India Ltd is 356 Cr..

What is the current Stock Price of Multibase India Ltd as on 24 February 2025?

The current stock price of Multibase India Ltd as on 24 February 2025 is ₹282.

What is the High / Low of Multibase India Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Multibase India Ltd stocks is 622/226.

What is the Stock P/E of Multibase India Ltd?

The Stock P/E of Multibase India Ltd is 24.4.

What is the Book Value of Multibase India Ltd?

The Book Value of Multibase India Ltd is 110.

What is the Dividend Yield of Multibase India Ltd?

The Dividend Yield of Multibase India Ltd is 18.8 %.

What is the ROCE of Multibase India Ltd?

The ROCE of Multibase India Ltd is 11.6 %.

What is the ROE of Multibase India Ltd?

The ROE of Multibase India Ltd is 8.58 %.

What is the Face Value of Multibase India Ltd?

The Face Value of Multibase India Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Multibase India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE